Omnicell (NASDAQ: OMCL) reported Q4 EPS of $0.54, $0.02 better than the analyst estimate of $0.52. Revenue for the quarter came in at $197.9 million versus the consensus estimate of $205.14 million.

2018 Guidance:

For 2018, we will adopt ASU 2014-09 Revenue from Contracts with Customers, which impacts the timing of revenue recognition and requires the presentation of certain costs previously reported as selling expenses as a reduction of revenue, both of which are not anticipated to be material. The reclassification of selling costs will result in a reduction of net sales, but has no impact on operating income or net earnings.

For the first quarter of 2018, the Company expects non-GAAP revenue to be between $174 million and $179 million, which includes the impact of reclassification of selling costs as a reduction of revenue. The Company expects first quarter of 2018 non-GAAP earnings to be between $0.22 and $0.28 per share.

GUIDANCE:

Omnicell sees FY2018 EPS of $1.85-$2.05, versus the consensus of $1.98. Omnicell sees FY2018 revenue of $780-800 million, versus the consensus of $807.16 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.